Management of late distant metastases after trimodality therapy for esophageal cancer

Ann Thorac Surg. 2003 Nov;76(5):1742-3. doi: 10.1016/s0003-4975(03)00653-2.

Abstract

Trimodality therapy has been shown in preliminary studies to increase survival in esophageal cancer. Distant recurrence remains the main pattern of failure. A case of aggressive treatment of two metachronous solitary visceral metastases is presented.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / secondary*
  • Adenocarcinoma / therapy*
  • Biopsy, Needle
  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / secondary*
  • Brain Neoplasms / therapy
  • Cerebellum / pathology
  • Cerebellum / surgery
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Esophageal Neoplasms / pathology*
  • Esophageal Neoplasms / therapy*
  • Esophagectomy / methods
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Radiotherapy, Adjuvant
  • Risk Assessment
  • Tomography, X-Ray Computed
  • Treatment Outcome